JP2025500917A5 - - Google Patents

Info

Publication number
JP2025500917A5
JP2025500917A5 JP2024536124A JP2024536124A JP2025500917A5 JP 2025500917 A5 JP2025500917 A5 JP 2025500917A5 JP 2024536124 A JP2024536124 A JP 2024536124A JP 2024536124 A JP2024536124 A JP 2024536124A JP 2025500917 A5 JP2025500917 A5 JP 2025500917A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
pharmaceutically acceptable
solvate
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500917A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081504 external-priority patent/WO2023114809A1/en
Publication of JP2025500917A publication Critical patent/JP2025500917A/ja
Publication of JP2025500917A5 publication Critical patent/JP2025500917A5/ja
Pending legal-status Critical Current

Links

JP2024536124A 2021-12-16 2022-12-14 Ｍｅｔキナーゼの阻害剤 Pending JP2025500917A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163290291P 2021-12-16 2021-12-16
US63/290,291 2021-12-16
US202263301267P 2022-01-20 2022-01-20
US63/301,267 2022-01-20
US202263380049P 2022-10-18 2022-10-18
US63/380,049 2022-10-18
US202263386647P 2022-12-08 2022-12-08
US63/386,647 2022-12-08
PCT/US2022/081504 WO2023114809A1 (en) 2021-12-16 2022-12-14 Inhibitors of met kinase

Publications (2)

Publication Number Publication Date
JP2025500917A JP2025500917A (ja) 2025-01-15
JP2025500917A5 true JP2025500917A5 (https=) 2025-12-23

Family

ID=85199244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536124A Pending JP2025500917A (ja) 2021-12-16 2022-12-14 Ｍｅｔキナーゼの阻害剤

Country Status (12)

Country Link
US (2) US11753395B2 (https=)
EP (1) EP4448510A1 (https=)
JP (1) JP2025500917A (https=)
KR (1) KR20240121851A (https=)
AU (1) AU2022413540A1 (https=)
CA (1) CA3240907A1 (https=)
CL (1) CL2024001756A1 (https=)
CO (1) CO2024009144A2 (https=)
IL (1) IL313548A (https=)
MX (1) MX2024007444A (https=)
TW (1) TW202333709A (https=)
WO (1) WO2023114809A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023114809A1 (en) 2021-12-16 2023-06-22 Kinnate Biopharma Inc. Inhibitors of met kinase
CN121038792A (zh) * 2023-04-17 2025-11-28 赛琳治疗公司 用met激酶抑制剂治疗癌症
WO2024259060A1 (en) * 2023-06-16 2024-12-19 Kinnate Biopharma Inc. Inhibitors of met kinase
WO2025096463A1 (en) * 2023-10-30 2025-05-08 Vibliome Therapeutics, Llc Plk4 modulators

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
EP0860433B1 (en) 1995-11-07 2002-07-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
JO2785B1 (en) 2003-05-27 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinazoline derivatives
US7459562B2 (en) 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US20070155746A1 (en) 2005-12-23 2007-07-05 Kalypsys, Inc. Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
JP2009539878A (ja) 2006-06-08 2009-11-19 アレイ バイオファーマ、インコーポレイテッド キノリン化合物および使用方法
US20090049035A1 (en) 2007-08-14 2009-02-19 International Business Machines Corporation System and method for indexing type-annotated web documents
JP2010126530A (ja) 2008-12-01 2010-06-10 Takeda Chem Ind Ltd 縮合複素環誘導体およびその用途
CN102573994B (zh) 2009-08-06 2015-06-24 默克专利有限公司 双环脲化合物
EP2423208A1 (en) 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
CN102827186A (zh) 2011-06-16 2012-12-19 中国科学院上海药物研究所 一类吡啶并五元杂环衍生物及其制备方法和用途
JP2015507606A (ja) 2011-11-22 2015-03-12 デシフェラ ファーマシューティカルズ，エルエルシー 抗癌および抗増殖作用を示すピリドンアミドおよび類似体
WO2013180949A1 (en) * 2012-05-27 2013-12-05 Ning Xi Substituted quinoline compounds and methods of use
CN103508961B (zh) 2012-06-26 2015-07-22 中美冠科生物技术（太仓）有限公司 抗肿瘤药物
EP3003315B1 (en) 2013-06-06 2018-01-17 Lead Discovery Center GmbH A quinoline inhibitor of the macrophage stimulating 1 receptor mst1r
KR101505783B1 (ko) 2014-08-01 2015-03-25 씨제이헬스케어 주식회사 신규한 피롤로피리디닐옥시페닐아미드 유도체 및 이의 용도
SG11201707638UA (en) 2015-04-14 2017-10-30 Qurient Co Ltd Quinoline derivatives as tam rtk inhibitors
CN105153026B (zh) 2015-08-21 2018-02-02 江西科技师范大学 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用
CN105732616B (zh) 2016-01-08 2018-07-27 江西科技师范大学 含联芳基酰胺结构的吡咯并吡啶类化合物及其制备方法和应用
CN109896997A (zh) 2017-12-08 2019-06-18 中国药科大学 N－酰基苯胺类c－Met激酶抑制剂的制备方法及其用途
UY38349A (es) 2018-08-30 2020-03-31 Array Biopharma Inc Compuestos de pirazolo[3,4-b]piridina como inhibidores de cinasas tam y met
CN111196814B (zh) 2018-11-19 2022-12-06 北京赛特明强医药科技有限公司 芳环连二噁烷并喹唑啉或喹啉类化合物、组合物及其应用
JP2022551422A (ja) * 2019-09-26 2022-12-09 エグゼリクシス， インコーポレイテッド ピリドン化合物およびタンパク質キナーゼの調節における使用の方法
WO2023114809A1 (en) 2021-12-16 2023-06-22 Kinnate Biopharma Inc. Inhibitors of met kinase

Similar Documents

Publication Publication Date Title
JP2025500917A5 (https=)
RU2328486C2 (ru) Производные 2-пиридона в качестве ингибиторов нейтрофильной эластазы
JP2021011495A5 (https=)
RU2404979C2 (ru) 2,4-ди(аминофенил)пиримидины в качестве ингибиторов рlk-киназ
RU2019136279A (ru) C5 -Анилинохиназолиновые соединения и их использование в лечении рака
RU2005137403A (ru) Новые замещенные 3-сера-индолы
JP2020502092A5 (https=)
RU2008127501A (ru) Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов
JP2017519781A5 (https=)
RU2004127925A (ru) N3-алкилированные бензимидазольные производные в качестве ингибиторов мек
JP2006524222A5 (https=)
RU2001125893A (ru) Производные 3-фенилпиридина и их применение в качестве антагонистов рецептора NK-1
JP2018536634A5 (https=)
JP2021530442A5 (https=)
JP2005524609A5 (https=)
JP2007520440A5 (https=)
JP2005513065A5 (https=)
JP2023552610A5 (https=)
RU2004113207A (ru) Хинолиновые производные в качестве антагонистов нейропептида y
RU2001108494A (ru) Диазепановые производные или их соли
JP2020511536A5 (https=)
RU2003115426A (ru) Замещенные производные 2-фениламиноимидазолинфенилкетона в качестве антагонистов ip
JP2009537542A5 (https=)
JP2022511477A5 (https=)
RU2004112781A (ru) Производные пиперидина и их применение в качестве модуляторов активности рецепторов хемокинов (в частности ccr5)